The serum tryptase test: an emerging robust biomarker in clinical hematology.
about
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemiaCutaneous Mastocytosis with Persistent Blistering: Successful Treatment with Methylprednisolone and 3-Year Follow-Up Management.Anaphylaxis in an urban Belgian emergency department: epidemiology and aetiology.A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation.
P2860
The serum tryptase test: an emerging robust biomarker in clinical hematology.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The serum tryptase test: an emerging robust biomarker in clinical hematology.
@ast
The serum tryptase test: an emerging robust biomarker in clinical hematology.
@en
type
label
The serum tryptase test: an emerging robust biomarker in clinical hematology.
@ast
The serum tryptase test: an emerging robust biomarker in clinical hematology.
@en
prefLabel
The serum tryptase test: an emerging robust biomarker in clinical hematology.
@ast
The serum tryptase test: an emerging robust biomarker in clinical hematology.
@en
P2093
P2860
P1476
The serum tryptase test: an emerging robust biomarker in clinical hematology
@en
P2093
Andreas Reiter
Hans-Peter Horny
Jason Gotlib
Karl Sotlar
Michel Arock
Wolfgang R Sperr
P2860
P304
P356
10.1586/17474086.2014.955008
P577
2014-08-28T00:00:00Z